LMIM
Lockheed Martin Investment Management Portfolio holdings
AUM
$2.74B
This Quarter Return
+4.48%
1 Year Return
+18.07%
3 Year Return
+58.38%
5 Year Return
+90.71%
10 Year Return
+173.39%
AUM
$1.89B
AUM Growth
+$1.89B
(+3.6%)
Cap. Flow
-$5.42M
Cap. Flow
% of AUM
-0.29%
Top 10 Holdings %
Top 10 Hldgs %
61.58%
Holding
148
New
18
Increased
26
Reduced
38
Closed
17
Top Buys
| 1 |
Energy Select Sector SPDR Fund
XLE
|
$89.1M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$35.8M |
| 3 |
iShares MSCI Europe Financials ETF
EUFN
|
$10.3M |
| 4 |
Vanguard FTSE Europe ETF
VGK
|
$7.58M |
| 5 |
Health Care Select Sector SPDR Fund
XLV
|
$5.21M |
Top Sells
Sector Composition
| 1 | Technology | 3.87% |
| 2 | Financials | 3.17% |
| 3 | Communication Services | 1.92% |
| 4 | Healthcare | 1.37% |
| 5 | Consumer Discretionary | 0.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Ambarella
AMBA
$3.36B
| $529K | 0.03% |
10,800
-10,800
| -50% | -$529K |
|
127
Evolent Health
EVH
$1.11B
| $510K | 0.03% |
28,650
| – | – |
|
128
DexCom
DXCM
$30.9B
| $387K | 0.02% |
7,900
-9,500
| -55% | -$465K |
|
129
Mastercard
MA
$536B
| $339K | 0.02% |
+2,400
| New | +$339K |
|
130
Gilead Sciences
GILD
$140B
| $324K | 0.02% |
+4,000
| New | +$324K |
|
131
Teva Pharmaceuticals
TEVA
$21.5B
| $317K | 0.02% |
+18,000
| New | +$317K |
|
|
UN
132
DELISTED
Unilever NV New York Registry Shares
UN
| – | – |
-183,500
| Closed | -$10.1M |
|
133
Western Digital
WDC
$29.8B
| – | – |
-22,500
| Closed | -$1.99M |
|
134
Stryker
SYK
$149B
| – | – |
-9,000
| Closed | -$1.25M |
|
135
Seagate
STX
$37.5B
| – | – |
-92,000
| Closed | -$3.57M |
|
136
Sanofi
SNY
$122B
| – | – |
-139,300
| Closed | -$6.67M |
|
137
Newell Brands
NWL
$2.64B
| – | – |
-19,000
| Closed | -$1.02M |
|
138
Novartis
NVS
$248B
| – | – |
-156,100
| Closed | -$13M |
|
139
Novo Nordisk
NVO
$252B
| – | – |
-109,500
| Closed | -$4.7M |
|
140
Halliburton
HAL
$18.4B
| – | – |
-24,000
| Closed | -$1.03M |
|
141
GSK
GSK
$79.3B
| – | – |
-143,900
| Closed | -$6.21M |
|
142
Elevance Health
ELV
$72.4B
| – | – |
-3,500
| Closed | -$658K |
|
143
Diageo
DEO
$61.1B
| – | – |
-39,100
| Closed | -$4.69M |
|
144
AstraZeneca
AZN
$255B
| – | – |
-147,800
| Closed | -$5.04M |
|
145
Boston Scientific
BSX
$159B
| – | – |
-137,000
| Closed | -$3.8M |
|
146
British American Tobacco
BTI
$120B
| – | – |
-116,200
| Closed | -$7.96M |
|
147
AB InBev
BUD
$116B
| – | – |
-47,700
| Closed | -$5.26M |
|
148
Comerica
CMA
$9B
| – | – |
-23,500
| Closed | -$1.72M |
|